secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001628280-23-014561
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q1 revenue down 16.4% to $349M; guides Q2 revenue $250-270M, EPS $1.32-1.44
--------------------------------------------------------------------------------

- Revenue $349M (-16.4% YoY); net income $40M ($3.67 diluted EPS) vs $41.8M ($3.59) prior year.
- Active earning OPTA VIA coaches 58,700 (-8.1%); revenue per coach $5,945 (-9.0%).
- Gross profit margin 70.6% vs 72.4% due to cost inflation and lower volumes.
- Q2 2023 guidance: revenue $250-270M, diluted EPS $1.32-1.44, effective tax rate 24.5-26.25%.
- Quarterly dividend $1.65/share payable May 9; cash $123.7M, no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828023014561/0001628280-23-014561-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828023014561/med-20230501.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-014561

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer